The complaints, filed across various states, are all worded similarly and generally declare that medical spas and clinics are violating the Lanham Act by advertising their compounded semaglutide drugs as a comparison to Ozempic or Wegovy
Glutathione injections deliver this antioxidant directly into the bloodstream for maximum cellular uptake, supporting the body's natural defense systems where they are needed most
In 2019, the FDA granted approval for the release of Semaglutide in a tablet form called Rybelsus. In 2021, the company developed another Semaglutide brand named Wegovy, suitable for long-term obesity treatment
Diabetes Obes Metab 21(12):26192625
Footnotes Competing Financial Interests The authors declare that they have no competing financial interests
The Bottom Line Patients should have clear information about what these drugs can and cannot do, along with proper medical supervision that goes beyond just tracking weight, looking at muscle mass, nutrition, and overall health